Solimeno Luigi Piero, Pasta Gianluigi
Division of Orthopaedic Surgery and Traumatology, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Via F. Sforza, 28, 20122 Milan, Italy.
J Clin Med. 2017 Nov 22;6(11):107. doi: 10.3390/jcm6110107.
Today, major surgical procedures can be safely performed in hemophilic patients with chronic arthropathy, using available factor concentrates. In this setting, total knee replacement is considered the "gold standard", while the use of total ankle replacement is still debated. Indeed, the unsatisfactory results obtained with the previous available design of implants did not raise enthusiasm as knee or hip replacement. Recently, the introduction of new implant designs and better reported outcomes have renewed the interest in total ankle replacement in people with hemophilia. In this review, the role of replacement surgery in the treatment of chronic hemophilic arthropathy will be described.
如今，使用现有的凝血因子浓缩物，患有慢性关节病的血友病患者可以安全地接受大型外科手术。在这种情况下，全膝关节置换被视为“金标准”，而全踝关节置换的应用仍存在争议。事实上，以前使用的植入物设计所取得的不理想结果，并未像膝关节或髋关节置换那样引起人们的热情。最近，新植入物设计的推出以及更好的疗效报告，重新激发了血友病患者对全踝关节置换的兴趣。在这篇综述中，将描述置换手术在治疗慢性血友病性关节病中的作用。
